{"organizations": [], "uuid": "fe4254ec237e4cbc09bb7d34a828767755ce88a5", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180119.html", "section_title": "Archive News &amp; Video for Friday, 19 Jan 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-beijing-tiantan-biological-product/brief-beijing-tiantan-biological-products-unit-buys-three-blood-products-firms-idUSL3N1PE345", "country": "US", "domain_rank": 408, "title": "BRIEF-Beijing Tiantan Biological Products unit buys three blood products firms", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.004, "site_type": "news", "published": "2018-01-19T17:25:00.000+02:00", "replies_count": 0, "uuid": "fe4254ec237e4cbc09bb7d34a828767755ce88a5"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-beijing-tiantan-biological-product/brief-beijing-tiantan-biological-products-unit-buys-three-blood-products-firms-idUSL3N1PE345", "ord_in_thread": 0, "title": "BRIEF-Beijing Tiantan Biological Products unit buys three blood products firms", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "beijing tiantan biological products corp ltd", "sentiment": "negative"}, {"name": "brief-beijing tiantan biological products", "sentiment": "negative"}, {"name": "chengdu rongsheng pharmaceuticals", "sentiment": "none"}, {"name": "beijing headline news", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Jan 19(Reuters) - Beijing Tiantan Biological Products Corp Ltd\n* Says co acquires 10 percent stake in coâ€™s unit Chengdu Rongsheng Pharmaceuticals and holds 69.5 percent stake in the unit after acquisition\n* Says the unit buys three blood products firms\n* Previous news was disclosed on Dec. 1, 2017\nSource text in Chinese: goo.gl/s9jpiF\nFurther company coverage: (Beijing Headline News)\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html", "https://goo.gl/s9jpiF"], "published": "2018-01-19T17:25:00.000+02:00", "crawled": "2018-01-20T17:32:14.004+02:00", "highlightTitle": ""}